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Abstract
Background: Disturbances in glucose metabolism during pregnancy are associated with negative sequalae for
both mother and infant. The association between smoking and abnormal glucose tolerance (AGT) remains
controversial. Therefore, the aim of this study was to examine the relationship between smoking prior to and
during pregnancy and risk of AGT.
Methods: We utilized data from a prospective cohort of 1,006 Hispanic (predominantly Puerto Rican) prenatal care
patients in Western Massachusetts. Women reported pre- and early pregnancy smoking at recruitment (mean = 15
weeks) and mid pregnancy smoking at a second interview (mean = 28 weeks). AGT was defined as > 135 mg/dL
on the routine 1-hour glucose tolerance test (1-hr OGTT). We used multivariable regression to assess the effect of
pre, early, and mid-pregnancy smoking on risk of AGT and screening plasma glucose value from the 1-hr OGTT.
Results: In age-adjusted models, women who smoked > 0-9 cigarettes/day in pre-pregnancy had an increased risk
of AGT (OR = 1.90; 95% CI 1.02-3.55) compared to non-smokers; this was attenuated in multivariable models.
Smoking in early (OR = 0.48; 95% CI 0.21-1.10) and mid pregnancy (OR = 0.38; 95% CI 0.13-1.11) were not
associated with AGT in multivariable models. Smoking during early and mid pregnancy were independently
associated with lower glucose screening values, while smoking in pre-pregnancy was not.
Conclusions: In this prospective cohort of Hispanic women, we did not observe an association between smoking
prior to or during pregnancy and risk of AGT. Findings from this study, although based on small numbers of cases,
extend prior research to the Hispanic population.
Background
An estimated four to twelve percent of pregnancies are
complicated by some degree of abnormal glucose intol-
erance (AGT), including gestational diabetes mellitus
(GDM) as well as milder degrees of glucose tolerance
[1]; rates are higher in Hispanic women as compared to
non-Hispanic white women. Recently, the 7-year pro-
spective Hyperglycemia and Adverse Pregnancy Out-
come study found a consistent, linear increase in risk of
adverse perinatal outcomes (cesarean section, fetal size,
neonatal hypoglycemia, and fetal hyperinsulinemia) over
the entire range of maternal blood glucose levels [2],
not just with GDM, suggesting that identifying risk
factors for milder degrees of disturbances in glucose
metabolism is critical for maternal and offspring health.
Cigarette smoking remains common during pregnancy
[3,4], but research examining the role of smoking as a
risk factor for AGT is limited. Smoking has been asso-
ciated with increased insulin resistance and type 2 dia-
betes in non-pregnant women [5]. However, whether
smoking is a risk factor for glucose disturbances during
pregnancy is less clear. Physiologic studies suggest that
smoking may increase circulating levels of catechola-
mines, compounds involved in insulin resistance, and
that nicotine may have direct toxic effects on pancreatic
beta cell function [6-8].
Epidemiologic evidence supporting the role of smok-
ing as a risk factor for GDM is limited and there is
major heterogeneity in research design [9]. With few
exceptions, the majority of studies have examined smok-
ing as a dichotomous variable [10-15] and only five
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any medium, provided the original work is properly cited.studies presented adjusted odds ratios [16-20]. Further-
more, only one prior study has been conducted in a
Hispanic population [21]. There is some evidence that
nicotine metabolism varies by race, leading to higher
and lower nicotine exposure per cigarette among
African-Americans and Chinese-Americans, respectively,
although Hispanics appear to metabolize nicotine at the
same rate as whites [22,23]. In addition, smoking
patterns vary markedly among US Hispanic women
according to country of origin, with Puerto Rican
women having the highest rates of smoking during preg-
nancy compared to Hispanics from other countries [4].
One study found that 41% of female Puerto Rican smo-
kers preferred menthol brands of cigarettes, and that
menthol smokers may have larger inhaled volumes and
higher cotinine levels than non-menthol smokers [24].
These characteristics of cigarette use among Hispanics
may impact the effect of smoking on AGT in this
population.
This is important as Hispanics are one of the fastest-
growing segments of the US population, comprising
14.7% of the female population in 2008 [25]. Over 24%
of all US births in 2007 were to Hispanics [26], repre-
senting the highest fertility rate of any race or ethnic
group. Health status varies widely between Hispanic
subgroups, with rates of adverse birth outcomes highest
for Puerto Rican women [27].
Therefore, we prospectively examined the association
between smoking during pre, early, and mid pregnancy
and risk of AGT among a population of predominantly
Puerto Rican prenatal care patients at a large tertiary
care facility. We hypothesized that smokers during pre,
early, or mid pregnancy would have an increased risk of
AGT as compared to non-smokers. The current study
contributes to the existing literature by examining the
association between smoking during pregnancy, includ-
ing cigarettes per day, and risk of AGT in a high-risk
population of Hispanic prenatal care patients. To our
knowledge, this is first prospective study of smoking and
AGT in a Puerto Rican population.
Methods
Study Design
The Latina GDM Study was designed to examine physi-
cal activity and risk of GDM among Hispanic (predomi-
nantly Puerto Rican) women. Details of the study have
been provided elsewhere [28]. Briefly, the study was
b a s e da tt h ep u b l i cc l i n i ca n dm i d w i f e r yp r a c t i c eo f
Baystate Medical Center, a large tertiary care facility in
Western Massachusetts. Between September 2000 and
December 2003, prenatal care patients who self-identi-
fied as Hispanic were recruited prior to the 24
th week of
gestation (mean = 15 weeks of gestation, standard devia-
tion (SD) = 5 weeks). Reasons for exclusions included
age over 40 or under 16 years; non-Hispanic ethnic
group; history of type 2 diabetes; hypertension or heart
disease; chronic renal disease; non-singleton pregnancy;
> 24 weeks of gestation at first interview; or prior parti-
cipation in the study. All participants signed a written
informed consent. The study was approved by the Insti-
tutional Review Boards of the University of Massachu-
setts-Amherst and Baystate Medical Center.
Bilingual interviewers collected information on current
smoking status as well as smoking in the year prior to
pregnancy. Information on sociodemographic character-
istics and lifestyle factors was also collected. A second
interview conducted in mid pregnancy (mean = 28
weeks, SD = 5 weeks) updated information on cigarette
smoking. A subsample of participants completed a food
frequency questionnaire (FFQ) at their mid-pregnancy
visit. Medical and obstetrical history as well as clinical
characteristics of the current pregnancy were abstracted
from medical records after delivery.
A total of 1,231 prenatal care patients were enrolled in
the Latina GDM Study. For the current analysis, we
excluded women with a spontaneous or therapeutic
abortion or preterm birth before 28 weeks (n = 48),
women who did not deliver at Baystate (n = 123), and
women not screened for GDM (n = 54), resulting in a
sample size of 1,006 participants.
Assessment of Cigarette Smoking
Cigarette smoking was assessed using questions
designed by the Pregnancy Risk Assessment Monitoring
System (PRAMS), a surveillance project of the Centers
for Disease Control and Prevention [29]. Specifically, for
the pre-pregnancy period, participants were asked how
many cigarettes or packs of cigarettes were smoked on
an average day (one pack = 20 cigarettes) in the year
prior to pregnancy. Women were then classified as non-
smokers (referent category) or smokers (> 0-9, or 10+
cigarettes per day) during the pre-pregnancy period.
Participants also self-reported the number of cigarettes
or packs smoked on an average day since pregnancy
awareness ("early pregnancy” smoking). At the second
interview, smoking since the last interview was collected
("mid pregnancy” smoking). For early pregnancy, women
were classified as 1) non-smokers (i.e., non-smokers in
both pre and early pregnancy), 2) former smokers (i.e.,
smokers in pre-pregnancy but non-smokers in early
pregnancy), or 3) smokers in early pregnancy. For mid
pregnancy, women were classified as 1) non-smokers
(i.e., non-smokers in pre, early, and mid pregnancy), 2)
former smokers (i.e., smokers in pre or early pregnancy
but non-smokers in mid pregnancy), or 3) smokers in
mid pregnancy. Women who reported being non-smo-
kers in either the early or mid pregnancy periods but
were missing smoking information for the previous time
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gorized with former smokers for that previous period in
order to preserve a reference group of confirmed non-
smokers who did not smoke in any prior pregnancy
period. Analyses were limited to the women with com-
plete information on smoking during the pre (n = 912),
early (n = 847), and mid (n = 697) pregnancy time peri-
ods, respectively. However, as a secondary analysis we
restricted the analysis to participants with complete data
in all three time periods.
Assessment of Abnormal Glucose Tolerance
Prenatal care patients were screened for GDM between
the 24
th and 28
th week of gestation as part of routine
hospital protocol. The screening test consisted of
administering a random (non-fasting) 50-g glucose load
and a plasma glucose determination one hour later
(1-hr OGTT). If the plasma glucose value was > 135
mg/dL, the woman was classified as having AGT in
accordance with American Diabetes Association criteria
[30]. We also evaluated the 1-hr OGTT plasma glucose
values as a continuous outcome measure.
Covariate Assessment
We collected information about potential risk factors for
AGT. Maternal age, education level, and annual house-
hold income were assessed at the baseline interview.
At this time interviewers also assessed language prefer-
ence, birth place, and pregnancy behaviors including
alcohol consumption and physical activity. Physical
activity was assessed via the Kaiser Physical Activity Sur-
v e y( K P A S )[ 3 1 ] .T h eK P A Sp r o v i d e saq u a n t i f i a b l e
index value ranging from 1 to 5 for each domain speci-
fic response for four domains of activity: household/car-
egiving, occupational, active living, and sports/exercise
using the scoring procedures outlined by Sternfeld et al.
[31] (possible range: 1.0 to 5.0). Domain-specific activity
indices were summed to calculate total activity (possible
range: 4.0 to 20.0). Total activity was categorized in
quartiles.
Medical characteristics including parity (number of
previous live births), pre-pregnancy body mass index
(BMI) (weight in kg/height in m
2), family history of type
2 diabetes, personal history of diagnosed GDM, and
hypertension in the current pregnancy were abstracted
from the medical record. Rate of weight gain up to the
time of the GDM screen was calculated by subtracting
pre-pregnancy weight from weight at the GDM screen
and dividing by the gestational age at the screen.
Dietary intake was assessed among a subsample of
participants through a FFQ designed specifically for His-
panics in the Northeastern United States [32]. Dietary
variables included total fat, saturated fat, protein, carbo-
hydrate, fiber, total calories, and percent calories from
fat, protein, and carbohydrates. Of the 628 completed
FFQs, those with more than 12 blank items or with
implausible caloric intake (< 600 or > 4500 calories)
were excluded, yielding a sample of 566 participants for
the diet analysis.
Data Analysis
Using logistic regression, we calculated odds ratios
(ORs) and 95% confidence intervals (CI) for AGT com-
paring level of cigarette smoking in pre, early, and mid
pregnancy to non-smokers in that time period. Age,
BMI, and gestational weight gain were ap r i o r ifactors
included in multivariable models due to their established
associations with AGT [10]. We also independently
included each covariate in the model; those factors that
changed the association between smoking and AGT by
10% or more (i.e., parity and education) were included
in the final multivariable models. The analysis of pre-
pregnancy smoking was adjusted for smoking during
pregnancy. In order to retain a consistent sample size
between age-adjusted and multivariable analyses, women
with missing information on any covariate (e.g., age,
BMI, weight gain, parity, and education) were retained
in the model by assigning their covariate category to
‘missing’.
We then examined the association between smoking
category and screening glucose from the 1-hr OGTT as
a continuous outcome variable. After verifying normality
of glucose values, we used multivariable linear regres-
sion to generate age-adjusted and adjusted beta coeffi-
cients, standard errors, and p values for women in each
exposure category (former smokers, > 0-9, 10+ cigar-
ettes per day) as compared to non-smokers.
Finally, we conducted a sub-analysis among the
women with dietary data to examine if dietary variables
confounded the association between smoking and AGT.
All analyses were conducted using the Statistical
Analysis System (SAS Institute, Cary, NC) version 9.1.
Results
T h em a j o r i t yo fw o m e nw e r ey o u n g( 7 2 %>2 5y e a r s ) ,
55% had not graduated from high school and 60% had an
annual household income less than $15,000 (Table 1).
The population had a number of risk factors for AGT
including overweight or obesity (49%) and family history
of diabetes (64%).
A total of 119 (11.8%) participants were classified
with AGT. Higher levels of age, education, income,
pre-pregnancy BMI, family history of type 2 diabetes,
and personal history of GDM were associated with
increased risk of AGT (Table 1). In addition, women
with AGT were more likely to have hypertension in
the current pregnancy. Parity, weight gain up to the
time of GDM screen, language preference, birthplace,
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Page 3 of 9Table 1 Distribution of sociodemographic, medical, acculturation, and behavioral characteristics according to
abnormal glucose tolerance (AGT); Latina Pregnancy Study, 2000-2004
Total AGT cases
Yes No
N% N % N %
Total 1006 100.0 119 11.8 887 88.2
Sociodemographic Characteristics
Age (years)
16-19 340 33.8 23 19.3 317 35.7
20-24 381 37.9 39 32.8 342 38.6
25-29 177 17.6 26 21.9 151 17.0
30-40 108 10.7 31 26.1 77 8.7
Education
< High School 502 55.2 47 45.2 455 56.5
High/Trade/Technical School 293 32.2 34 32.7 259 32.2
Some College/Graduate 114 12.5 23 22.1 91 11.3
Annual household income
< $15,000 333 59.5 44 57.9 289 59.7
$15,000-30,000 171 30.5 18 23.7 153 31.6
> $30,000 56 10.0 14 18.4 42 8.7
Medical Characteristics
Parity
0 393 39.2 36 30.5 357 40.3
1-2 491 49.0 491 54.2 427 48.3
3+ 119 11.9 18 15.3 101 11.4
Pre-pregnancy BMI (kg/m
2)
< 20 128 13.0 10 8.7 118 13.6
20-24.99 371 37.6 26 22.6 345 39.5
25-29.99 245 24.8 32 27.8 213 24.5
30+ 242 24.5 47 40.9 195 22.4
Family history of diabetes
No 339 35.8 25 22.7 314 37.5
Yes 609 64.2 85 77.3 524 62.5
Personal history of GDM
No 956 95.9 107 91.4 849 96.5
Yes 41 4.1 10 8.6 31 3.5
Weight gain up to glucose screen
1 (lbs/week)
0-< 0.5 253 31.4 29 33.7 224 31.2
0.5-< 1.0 367 45.6 37 43.0 330 45.9
1.0+ 185 23.0 20 23.3 165 22.9
Current hypertension
No 961 95.5 109 91.6 852 96.0
Yes 45 4.5 10 8.4 35 4.0
Acculturation Variables
Language preference
English Only 655 66.2 69 58.5 586 67.2
Both English and Spanish 141 14.2 22 18.6 119 13.6
Spanish Only 194 19.6 27 22.9 167 19.2
Birthplace
United States 488 53.3 52 49.5 436 53.8
Other 427 46.7 53 50.5 374 46.2
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were not associated with AGT.
Approximately one-third of participants (35%)
reported smoking cigarettes prior to pregnancy, while
20% of women reported smoking cigarettes during early
pregnancy and 17% in mid pregnancy (Table 2).
Women who smoked during pregnancy were predomi-
nantly light smokers, with 16% smoking > 0-9 cigarettes
per day and 4% smoking 10 or more cigarettes per day
in early pregnancy. Compared to non-smokers, smokers
were more likely to be multiparous, have lower educa-
tion level and household income, and to drink alcohol
during pregnancy (data not shown). Smokers were also
more likely to prefer using only English and to be born
in the United States.
After adjusting for age and early pregnancy smoking,
women who smoked in pre-pregnancy did not have an
increased risk of AGT (OR = 1.42; 95% CI 0.82-2.46) as
compared to non-smokers. However, when evaluated
according to dose, women who smoked > 0-9 cigarettes
per day in pre-pregnancy had an increased risk of AGT
(OR = 1.90; 95% 1.02-3.55) compared to pre-pregnancy
non-smokers, while those who smoked 10+ cigarettes
per day were not at increased risk (OR = 0.95; 95%
0.45-2.00) (Table 2). The increased risk for light smok-
ing during pre-pregnancy was attenuated after adjust-
ment for gestational weight gain (OR = 1.73; 95% CI
0.84-3.58). Similarly, smokers in early (OR = 0.48; 95%
CI 0.21, 1.10) and mid pregnancy (OR = 0.38; 95% CI
0.13-1.11) did not have an increased risk of AGT as
compared to non-smokers in multivariable models.
When we restricted the analysis to participants with
c o m p l e t es m o k i n gd a t ai na l lt h r e et i m ep e r i o d s
(n = 609) findings were virtually unchanged.
We then examined the association between smoking
category and continuous glucose levels from the 1-hr
OGTT (mean = 101.9 mg/dL) (Table 3). Regardless of
dose, pre-pregnancy smoking was not associated with
glucose level in age-adjusted and multivariable (b = -2.00,
p = 0.36) models. However, women who smoked in early
pregnancy (b = -4.60, p = 0.03) and in mid-pregnancy
(b =- 6 . 0 8 ,p=0 . 0 1 )h a dl o w e rm e a ng l u c o s el e v e l sa s
compared to non-smokers after adjusting for AGT risk
factors.
Finally, to determine if the association between smok-
ing and risk of AGT was confounded by dietary intake,
we evaluated the association between smoking during
pregnancy and AGT in the subset of women with com-
plete dietary intake information (n = 566). Smokers con-
sumed significantly more total fat (p = 0.004) and
saturated fat (p = 0.0003) and significantly less fiber
(p = 0.005), carbohydrates (p = 0.01), and fewer calories
(p = 0.05) than non-smokers. After adjusting for dietary
factors, findings were not substantively changed. For
example, the multivariable OR for early pregnancy smo-
kers as compared to non-smokers was 0.48 (95%
CI 0.18, 1.30).
Women who were not screened for GDM (n = 54) did
not differ from those who were screened for GDM in
terms of age, parity, education, BMI, family history of
diabetes, history of GDM, language preference, or smok-
ing in pre or early pregnancy (all p > 0.20). Similarly,
women missing smoking data during any pregnancy
time period did not differ from women missing such
data during other pregnancy time periods, nor from
women with complete information on smoking.
Discussion
In this prospective cohort study of Hispanic women,
results do not suggest an increased risk of AGT related
to smoking cigarettes. There was the suggestion that
light smoking in pre-pregnancy was associated with an
increased risk of AGT compared to non-smokers. Smok-
ing during early and mid pregnancy was not associated
with AGT. Cigarette smoking during early and mid preg-
nancy were associated with lower mean screening glucose
Table 1 Distribution of sociodemographic, medical, acculturation, and behavioral characteristics according to abnor-
mal glucose tolerance (AGT); Latina Pregnancy Study, 2000-2004 (Continued)
Pregnancy Behaviors
Alcohol Consumption
No 921 98.4 110 99.1 811 98.3
Yes (1+ drink/week) 15 1.6 1 0.9 14 1.7
Pregnancy physical activity
1
st quartile 227 25.9 25 24.3 202 26.1
2
nd quartile 226 25.8 22 21.4 204 26.4
3
rd quartile 213 24.3 24 23.3 189 24.5
4th quartile 210 24.0 32 31.0 178 23.0
1Rate of weight gain was analyzed as a continuous variable in multivariate models but is presented in categories here.
Note: Sums may not add to 1006 due to missing data for some covariates
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pared to non-smokers, independent of weight gain during
pregnancy.
Our findings of a suggestion of an increased risk for
pre-pregnancy light smoking is consistent with findings
among 14,613 participants in the Nurses Health Study
[33]. Specifically, Solomon et al. found that, compared to
non-smokers, pregravid smokers of 5+ cigarettes per day
had an increased risk of GDM (RR = 1.65; 95% CI 1.05-
2.58) compared to pregravid non-smokers. It is possible,
however, that observed increased risks among pre-preg-
nancy smokers may be due to the effect of quitting smok-
ing. Quitting or reducing the number of cigarettes
smoked during pregnancy may lead to increased gesta-
tional weight gain [34], a risk factor for AGT and GDM
[35]. Indeed, after controlling for gestational weight gain,
our observed increased risk for pre-pregnancy smoking
was attenuated.
Similarly, we observed that smoking in early and mid
pregnancy were not associated with AGT in age-
adjusted or multivariable analyses. Prior epidemiologic
studies have been conflicting. In a recent review article,
Wendland et al. obtained a crude odds ratio of 1.03
(99% CI 0.85-1.25) and an adjusted odds ratio of 0.95
(95% CI 0.85-1.07) for smoking during pregnancy and
risk of GDM [9]. In the only prior study to assess
Hispanic women (Brazil), Wendland et al. found that
women who smoked during pregnancy had a reduction
in risk of GDM (OR = 0.69; 95% CI 0.50-0.96) after
adjusting for GDM risk factors [21]. While there were
no significant differences in fasting and 1 h plasma glu-
cose means, those for 2 h glucose were significantly
lower in smokers (5.58+0.04 mmol/L), p < 0.01) in
adjusted analyses. Similarly, we found that smokers in
early and mid pregnancy had lower levels of plasma
screening glucose values as compared to non-smokers.
There is biologic plausibility for such an association.
Nicotine has been shown to block the release of inflam-
matory cytokines, inhibiting inflammation associated
with insulin resistance and thereby diminishing hyper-
glycemia [9]. Smoking-induced release of catecholamines
may also increase the metabolism of soluble nutrients,
Table 2 Odds ratios of abnormal glucose tolerance (AGT) according to smoking in pre, early, and mid pregnancy;
Latina Pregnancy Study, 2000-2004
Total
Population
AGT Cases Age-adjusted Age- and
weight-gain adjusted
Full
Multivariate Model
1
No. % No. % OR 95% CI OR 95% CI OR 95% CI
Pre-pregnancy
2
Non-smoker 596 65.3 70 11.7 1.00 referent 1.00 referent 1.00 referent
Smoker 316 34.7 35 11.1 1.42 [0.82, 2.46] 1.29 [0.69, 2.41] 1.27 [0.67, 2.38]
> 0-9 cigarettes/day 125 13.7 20 16.0 1.90 [1.02, 3.55] 1.73 [0.84, 3.58] 1.75 [0.83, 3.67]
10+ cigarettes/day 191 20.9 15 7.9 0.95 [0.45, 2.00] 0.89 [0.38, 2.07] 0.86 [0.37, 2.01]
Total 912 100.0 105 11.5
Early Pregnancy
Non-smoker
3 524 61.8 62 11.8 1.00 referent 1.00 referent 1.00 referent
Former smoker
4 153 18.1 24 15.7 1.50 [0.89, 2.52] 1.38 [0.76, 2.51] 1.28 [0.68, 2.41]
Smoker 170 20.1 11 6.5 0.49 [0.25, 0.94] 0.45 [0.20, 1.02] 0.48 [0.21, 1.10]
> 0-9 cigarettes/day 133 15.7 9 6.8 0.59 [0.28, 1.22] 0.49 [0.19, 1.29] 0.49 [0.19, 1.32]
10+ cigarettes/day 37 4.4 2 5.4 0.39 [0.09, 1.67] 0.49 [0.11, 2.18] 0.57 [0.12, 2.66]
Total 847 100.0 97 11.5
Mid Pregnancy
Non-smoker
3 387 55.5 43 11.1 1.00 referent 1.00 referent 1.00 referent
Former smoker
5 193 27.7 29 15.0 1.47 [0.87, 2.48] 1.16 [0.64, 2.10] 1.06 [0.57, 2.00]
Smoker 117 16.8 7 6.0 0.46 [0.20, 1.03] 0.36 [0.12, 1.02] 0.38 [0.13, 1.11]
> 0-9 cigarettes/day 93 13.3 6 6.5 0.62 [0.25, 1.53] 0.35 [0.10, 1.20] 0.36 [0.11, 1.24]
10+ cigarettes/day 24 3.4 1 4.2 0.27 [0.04, 2.08] 0.46 [0.06, 3.79] 0.53 [0.06, 4.67]
Total 697 100.0 79 11.3
1Multivariate model includes age, BMI, weight gain, parity, and education.
2Pre pregnancy analysis is also adjusted for early pregnancy smoking.
3Current non-smokers who did not previously smoke.
4Smoked in pre only; includes non-smokers in early pregnancy with unknown pre-pregnancy smoking status.
5Smoked in pre and/or early only; includes non-smokers in mid pregnancy with unknown pre or early smoking status.
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Smoking has also been consistently and negatively asso-
ciated with pre-eclampsia via physiological mechanisms
that may be similar [37]. These observations, however,
do not exclude the fact that smoking may increase risk
of type 2 diabetes in non pregnant women through dif-
ferent metabolic pathways. In addition, the higher doses
of smoking during the pre- or non-pregnancy periods
[38] may explain, in part, differences in associations
between pre-pregnancy vs. pregnancy smoking and risk
of AGT. Finally, it is important to note the established
adverse effects of smoking on birth outcomes.
Timing of smoking measurement during pregnancy
may also explain, in part, differences in study findings.
This meta analysis found that studies that assessed
smoking earlier in pregnancy [11,13-15,18] showed a
tendency to present an increased risk of GDM, while
studies that ascertained smoking later [10,16,19] showed
odds ratios slightly less than 1. The authors attribute
elevated risks observed in early pregnancy to failure to
identify smokers who quit or reduced the number of
cigarettes smoked, therefore erroneously attributing the
association found to smoking rather than to its reduc-
tion and subsequent possible increase in weight gain.
Smoking assessed later in pregnancy may therefore be a
more accurate assessment of true smoking status in
pregnancy.
Our study had several limitations. The relatively small
number of cases of AGT likely limited our power to
detect associations in analyses of AGT as a dichotomous
outcome and also precluded evaluating risk of frank
GDM. However, this limitation was not faced by the ana-
lysis of screening glucose level as a continuous outcome.
Like all studies relying on self-reported smoking informa-
tion, there may be some degree of misclassification in the
smoking variable. However, while women may be more
susceptible to biased reporting in smoking cessation trials
[39], evidence suggests that women are truthful when
self-reporting this information in observational studies
[40-43]. A study by Christensen et al. [42] also using a
structured, interviewer-administered questionnaire found
high validity for self-reported smoking when compared
to exhaled carbon monoxide levels. Ross et al. [40] com-
pared self-reported cigarette smoking with serum coti-
nine levels among pregnant women in Minnesota and
found that 96% of women who denied smoking reported
their status correctly (kappa = 0.86). The validity of self-
reported smoking during pregnancy has not been studied
Table 3 Linear regression of one-hour oral glucose tolerance test (1-hr OGTT) plasma values (mg/dL) on smoking
status, Latina Pregnancy Study, 2000-2004
Age-adjusted Age- and
weight-gain adjusted
Multivariate
a
Beta SE p-value
b Beta SE p-value
b Beta SE p-value
b
Pre-pregnancy
Non-smoker referent referent
Smoker -1.37 2.17 0.53 -2.86 -2.31 0.21 -2.00 2.19 0.36
> 0-9 cigarettes/day 0.51 2.58 0.84 -2.37 2.77 0.39 -0.72 2.62 0.78
10+ cigarettes/day -2.28 2.62 0.38 -3.35 2.78 0.23 -3.31 2.62 0.21
Early Pregnancy
Non-smoker
1 referent referent
Former smoker
2 -1.00 2.13 0.64 -2.73 2.28 0.23 -2.46 2.22 0.27
Smoker -5.47 1.99 < 0.01 -4.81 2.24 0.03 -4.60 2.08 0.03
> 0-9 cigarettes/day -5.61 2.27 0.01 -5.54 2.55 0.03 -5.16 2.31 0.03
10+ cigarettes/day -6.00 3.92 0.13 -5.25 4.35 0.23 -5.23 4.19 0.21
Mid Pregnancy
Non-smoker
1 referent referent
Former smoker
3 -1.21 2.06 0.55 -2.86 2.23 0.20 -2.04 2.06 0.32
Smoker -6.42 2.39 < 0.01 -5.99 2.66 0.02 -6.08 2.42 0.01
> 0-9 cigarettes/day -6.62 2.73 0.01 -7.13 2.96 0.02 -6.93 2.73 0.01
10+ cigarettes/day -7.55 4.91 0.12 -6.09 6.37 0.34 -6.00 5.05 0.23
1Current non-smokers who did not previously smoke.
2Smoked in pre only; includes non-smokers in early pregnancy with unknown pre-pregnancy smoking status.
3Smoked in pre and/or early only; includes non-smokers in mid pregnancy with unknown pre or early smoking status.
aAdjusted for age, BMI, education, parity, and birthplace. Pre-pregnancy model also adjusted for early pregnancy smoking (yes/no).
bThe reference group for statistical comparisons was non-smokers who did not previously smoke.
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Page 7 of 9in Hispanic women. However, the relatively high smok-
ing rates observed in the current study (35% pre-preg-
nancy, 20% early pregnancy) suggest that underreporting
of smoking may be less of a concern. In addition, by
incorporating a category for former smokers in our ana-
lysis, we avoid a limitation faced by prior studies that
combined ex-smokers with never smokers [9].
Although we had extensive information on established
risk factors for AGT, dietary variables were only avail-
able for a subset of women who completed the FFQ at
the mid pregnancy interview. However, findings in this
group were consistent with overall study findings. Simi-
larly, women who were not screened for GDM did not
differ from screened women in terms of any demo-
graphic, health, or smoking variables. Women who were
missing information on smoking did not differ from
women who were not missing this information.
Participants in this study were healthy Hispanic
women with a singleton pregnancy receiving prenatal
care. Because participants were predominantly light
smokers, we were not able to evaluate the effect of
heavy smoking on AGT. There is also some evidence
that nicotine metabolism varies by race [22,23]. There-
fore, care should be taken in generalizing to other racial
or ethnic groups whose smoking and AGT patterns
may differ. Indeed, the cigarette brands, tar content,
inhalation behavior, age of first use, and overall patterns
of smoking among Hispanics may differ from other
populations [24,28], and these characteristics of cigar-
ette use among Hispanics may impact the effect of
smoking on AGT.
Finally, BMI, parity, age, and gestational weight gain
may be important effect modifiers of the association
between smoking and AGT [9]. However, due to our
limited sample size we did not have adequate power to
assess effect modification by these factors with sufficient
precision. Future studies in Puerto Rican women should
evaluate the effect of these variables.
Conclusions
To our knowledge this is the first study to examine the
association between smoking and AGT among a Puerto
Rican population. This study contributes to the sparse
literature on smoking and AGT. We did not observe
any increased risk of AGT associated with smoking dur-
ing pregnancy; findings should be confirmed in other
study populations.
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